Previous 10 | Next 10 |
Radius Health (NASDAQ: RDUS ): Q1 Non-GAAP EPS of -$0.59 misses by $0.03 ; GAAP EPS of -$0.81 misses by $0.13 . More news on: Radius Health, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
TYMLOS® U.S. net sales of $48 million, with 61% year over year growth Our three Phase 3 studies continue to advance amid slowdown in recruitment due to COVID-19 pandemic. Anticipated data read-outs remain on track for second half of 2021 Due to anticipated impact of pandemi...
WALTHAM, Mass., April 28, 2020 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq:RDUS) today announced that the Company’s Board of Directors (the “Board”) granted G. Kelly Martin, in connection with his appointment a...
Jesper Hoeiland to step down as President and Chief Executive Officer in order to return to Denmark with his family Jesper will serve as a Senior Advisor to the Company to help facilitate a smooth transition Kelly Martin has been appointed President and Chief Executive Officer W...
Bausch Health Companies (NYSE: BHC ) initiated with Buy rating and $30 (84% upside) price target at Citigroup. Shares up 1% premarket. More news on: Radius Health, Inc., Immunomedics, Inc., West Pharmaceutical Services, Inc., Healthcare stocks news, Stocks on the move, , Re...
WALTHAM, Mass., April 20, 2020 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq: RDUS) announced today that it will release its first quarter financial results on Thursday, May 7, 2020. The Company will host a conference call and live audio webcast at 4:45 p.m. ET that day to discuss the results a...
New York City, NY: March 23, 2020 - Published via (Wired Release) - Recent Research and Future Market Potential of Fittings for Gas & Water Transmission Systems Market in Global Industry: 2020 Research and New Innovations in Oil and Gas Sector. The prime objective of the report is to...
Today, we will see why we should remain in wait-and-see mode for Radius Health ( RDUS ) until the end of 2020. Company overview Radius Health is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative endocrine therapeutics. Founded in ...
Image source: The Motley Fool. Radius Health (NASDAQ: RDUS) Q4 2019 Earnings Call Feb 27, 2020 , 8:00 a.m. ET Operator Continue reading
Radius Health, Inc. (RDUS) Q4 2019 Earnings Conference Call February 27, 2020 08:00 ET Company Participants Elhan Webb - Vice President, Investor Relations Jesper Høiland - President and Chief Executive Officer Pepe Carmona - Senior Vice President and Chief Financial Officer...
News, Short Squeeze, Breakout and More Instantly...
2024-07-19 10:10:00 ET July 19, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Biotech, Cleantech Sectors. The newest biotech companies are involved in blood disorder treat...
A look at the top 10 most actives in the United States Ocean Power Technologies Inc. (OPTT) rose 54.4% to $0.4264 on volume of 158,036,142 shares Versus Systems Inc. (VS) rose 73.5% to $2.29 on volume of 40,036,424 shares Tesla Inc. (TSLA) rose 5.3% to $220.97 on volume of 32,375,487 shar...
Ferrous, Nonferrous and Finished Steel Sales Volumes Up Sequentially Radius Board Declares Quarterly Dividend PORTLAND, Ore., July 02, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ: RDUS) today reported results for the third quarter of fiscal 2024 ended May 31, 2024. ...